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ABSTRACT:  
 
Background:  
Although genital herpes has emerged as the most common cause of genital ulcers in 
Southern Africa, treatment for herpes is not available routinely in the region. This study 
was done to determine the aetiology of genital ulcers in men in Durban and assess other 
STI –related symptoms, presentation and treatment patterns in this group.  
Methods: 
Polymerase chain reaction (PCR) tests were performed on specimens from consecutive 
male patients with genital ulcers to detect sexually transmitted pathogens. PCR was also 
performed for the detection of Neisseria gonorrhoeae, Chlamydia trachomatis, and 
Trichomonas vaginalis on urethral specimens from consecutive subjects with dysuria 
and/or urethral discharge. Antibody tests for syphilis and Herpes simplex virus type-2 
(HSV-2) and HIV antibodies were performed.  
Results: 
Of 162 patients enrolled with genital ulcers, 77.7% were HIV positive and 84.6% had 
antibodies to HSV-2. PCR results showed the following prevalences: HSV-2 53.7%, 
lymphogranuloma venereum 13.6%, Treponema pallidum 3.7%, Hemophilus ducreyi 
1.2%, mixed infections 6.2%, no pathogens identified 33.3%. One case of donovanosis 
was diagnosed clinically. In men with HSV-2 ulcers, delay before attendance recorded 
for 68 men was: 1-3 days (24%), 4-7 days  (47%), 8-14 days (12%), 15-30 days (12%), 
>30 days (6%). History taking using prompting increased the sensitivity but decreased 
the specificity and positive predictive value of reported genital ulceration when assessed 
against ulcers seen on examination. 
 
Conclusions: 
Men at risk of genital ulcers should be asked about relevant symptoms with and without 
prompting and examined clinically to maximize the likelihood of correct diagnosis and 
treatment. The finding of a high prevalence of HSV-2 and associated dysuria cautions 
against providing empiric treatment for gonorrhoea and chlamydia in ulcer patients with 
dysuria but without urethral discharge. Innovative strategies to limit the burden of HSV-2 
infection in this population are required. 
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Short summary 
 
In men with genital ulcers, prompting about other symptoms and clinical examination 
increased the likelihood of correct diagnosis.  Syndromic management strategies are 
challenged when the prevalence of genital herpes is high.  
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INTRODUCTION 
 
Genital ulcer disease (GUD) is a significant risk factor both for acquisition and onward 
transmission of HIV [1]. Early diagnosis and correct treatment of GUD is therefore an 
important element of any HIV control programme. In Durban, South Africa, a significant 
association between GUD and HIV was identified early on [2]. Syphilis and chancroid 
were then common in Durban as elsewhere in other parts of Africa [3, 4] but these 
conditions have both declined whilst genital herpes has emerged as the most frequent 
cause of GUD in Southern Africa [5-9].  
 
Current WHO STI treatment guidelines for GUD [10] now recommend treatment for 
chancroid and syphilis, and herpes if the prevalence is 30% or greater and,  if episodic 
therapy is chosen, treatment should be started during the prodrome or within one day 
after onset of lesions. However, there is a need to validate these guidelines that include 
counselling and education in Africa where the association between genital herpes and 
HIV is strong [11]. Treatment for genital herpes is still considered not to be feasible in 
the public sector due to lack of education with respect to symptom recognition and cost 
of therapy. We therefore sought to determine the aetiology of genital ulcers in men in 
Durban and assess other STI-related presentation and treatment patterns in this group that 
has a high prevalence of HIV.  
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METHODS 
 
Study population 
Consecutive men attending the Prince Cyril Zulu STI clinic in Durban for a new STI 
related problem between January-March 2004 were enrolled. Inclusion criteria for 
subjects were being sexually active, heterosexual, aged 16-75 and with the potential 
ability to return in two weeks. Subjects were included even though they may have had 
antibiotics in the previous 14 days. Signed consent was obtained from all subjects. At 
enrolment, sociodemographic data were obtained and a sexual behaviour questionnaire 
was administered by a trained interviewer in a face-to-face interview as reported 
previously [12].  Subjects were initially asked about their presenting complaint(s) as an 
open question. They were then asked if they had any additional complaints relating to 
genital ulceration, urethral discharge or dysuria. Information about duration of symptoms 
of the main initial unprompted complaint was collected. Clinical examination of the 
genital area was performed by a physician and information recorded on circumcision 
status. For this study, a genital ulcer was defined as an area with mucosal discontinuity 
and included healing lesions. Patients with vesicles only were also included. Additional 
information about symptoms and clinical signs was elicited during the examination. 
Cases were managed according to National STI syndromic guidelines.   
 
Specimen collection and laboratory methodology 
Ulcers were cleaned with a sterile dry gauze and impression smears made onto glass 
slides for the detection of Calymmatobacterium granulomatis by RapiDiff staining [7]. A 
specimen was then obtained by rolling a Probetec® cervical sponge over the base of the 
ulcer.  The material collected was suspended in 1.0 mL PBS, pH 7.6 and placed in an ice-
containing cooler box that was transported to the laboratory within 4 hours. DNA was 
extracted immediately on arrival using the Qiagen Blood and Tissue Mini Kit (Qiagen, 
USA). DNA was stored at -70o C until use. 
 
Polymerase chain reaction (PCR) was used for the detection of Herpes Simplex virus 
type 2 (HSV-2), Treponema pallidum (TP), Chlamydia trachomatis lymphogranuloma 
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venereum (LGV) biovars and Haemophilus ducreyi (HD) as described previously [7, 13]. 
LGV was diagnosed using a nucleic acid amplification test [14]: a PCR targeting the 60-
kDa cysteine-rich outer membrane protein was followed by digestion with AccI. C. 
Trachomatis L2 (ATCC VR-902B), C trachomatis trachoma biovar (a laboratory isolate 
from a cervical specimen) and water were included as controls in each run.  Detection of 
Neisseria gonorrhoeae and Chlamydia trachomatis on urethral specimens from subjects 
with dysuria and/or urethral discharge was done by means of the Strand Displacement 
Test (ProbeTec®) while an in-house PCR was used for Trichomonas vaginalis (TV) [15]. 
Specimens negative in all in-house PCR were subjected to a β-globin PCR. Those testing 
negative were excluded.  
 
HIV was diagnosed using Determine HIV 1/2 (Abbott Laboratories, Chicago, Il). Positive 
results were confirmed with a second serological test (Capillus HIV1/2, Trinity Biotech, 
USA). Serological testing for HSV-2 antibodies was by Focus HSV-2 (Focus 
Diagnostics, Cypress, CA) with a positive test defined as a ratio of 1.10 or more of the 
optical density reading over that of the cut-off calibrator provided with the kit. 
Serological testing for syphilis was with the rapid plasma reagin (RPR) test (Becton 
Dickinson, Cockeysville, MD), and Treponema pallidum haemagglutination assay 
(TPHA) (Omega Diagnostics, UK). All laboratory testing was carried out unlinked and 
anonymised. Data from the questionnaires were also anonymised and linked to the results 
of laboratory testing. Participants were offered voluntary counseling and testing for HIV 
at the clinic site. 
 
Swabs were taken from the subpreputial space in an additional nine patients without 
genital ulcers, five of whom had balanitis diagnosed clinically and four with marked 
inguinal lymphadenopathy. Fine needle biopsies from lymph nodes were obtained for 
PCR to diagnose herpes, syphilis, chancroid and LGV infections in four of these nine 
cases, three of whom had marked inguinal lymphadenopathy alone and one with both 
balanitis and inguinal lymphadenopathy. 
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Analysis and informed consent 
 
Questionnaire data were double-entered and validated using EpiData v3.0 [16]. 
Laboratory data were entered into an Excel spreadsheet (Microsoft). The sensitivity, 
specificity, positive and negative predictive values of self reported and prompted 
symptoms of genital ulceration in men with genital ulceration on clinical examination 
were assessed. Ethical approval for the study was obtained from the ethics committees of 
the Nelson Mandela Medical School, University of KwaZulu- Natal, Ethekwini 
Municipality Health Department Research Committee, Durban and the London School of 
Hygiene & Tropical Medicine. 
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RESULTS 
 
Six hundred and fifty men were asked to participate and none declined. Of these, 165 had 
genital ulcers confirmed on clinical examination and completed questionnaires. 
Laboratory results were available for 162. Table 1 shows some of the presenting features 
and microbial aetiology of patients with genital ulcers amongst STI clinic attenders. 
 
Demographic characteristics  
Data was available for 164/165 patients. The mean age was 29.9, standard deviation 7.8. 
Seventy six (46.3%) were new patients, 35 (21.2%) had no education or primary 
education only, 12 (7.3%) were married, 50 (30.3%) were living with a partner and 158 
(95.8%) were uncircumcised. Fourteen (8.5%) had received antibiotics in the last 14 
days. 
 
Analysis of symptoms 
 
Of the 161 men that complained of a genital ulcer spontaneously, 128 (79.5%) had ulcers 
on clinical examination (Table 1). An additional 30 complained of genital ulcers on direct 
questioning of whom 18 had ulcers confirmed on examination. Only one case presented 
with vesicles typical of genital herpes. Nineteen of those with ulcers on clinical 
examination did not complain of ulcers. Table 2 shows the sensitivity, specificity, 
positive and negative predictive values of self reported and prompted symptoms of 
genital ulcers compared to ulcers observed on clinical examination. History taking using 
prompting increased the sensitivity of reported genital ulceration from 77.6% to 88.5% 
but reduced both the specificity from 93.2% to 90.7% and the positive predictive value 
(PPV) from 79.5% to 76.4%.  
 
Microbiology and serology  
Of the 162 patients with genital ulcers confirmed by clinical examination and with 
samples for microbiological analysis, 126 (77.7%) were HIV positive and 137/160 
(84.6%) had antibodies to HSV-2. PCR results showed the following prevalences: HSV-2 
87 (53.7%), LGV 22 (13.6%), syphilis six (3.7%), chancroid two (1.2%), mixed 10 
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(6.2%) including seven with genital herpes and LGV, two with syphilis and LGV and one 
with chancroid and LGV. The prevalence of HIV in those with HSV-2 and LGV 
infections detected in ulcers was 77% and 86.4% respectively. One case of donovanosis 
was diagnosed clinically. No pathogens were identified in 54 (33.3%) in whom eight 
(14.8%) had both positive TPHA and RPR tests, 46 (85.2%) had antibodies to HSV-2 and 
40 (74.1%) were HIV positive. LGV was confirmed in an additional four patients, all 
HIV positive, without ulcers, three from material obtained by fine needle aspiration from 
inguinal lymph nodes and one by swabbing the subpreputial space. 
 
Duration of ulcers before presentation 
 
The duration of delay before presentation to the clinic in all patients with genital ulcers 
(n=120) was 0-3 days in 20 (16.7%), 4-7 days in 55 (45.8%), 8-14 days in 19 (15.8%), 
15-30 days in 13 (10.8%) and > 30 days in 18 (10.8%). The duration of ulceration was 
available for 68 of the men with genital herpes confirmed by PCR testing in whom the 
delay before attending was 0-3 days in 16 (23.5%), 4-7 days in 32 (47.1%), 8-14 days in 
eight (11.8%), 15-30 days in eight (11.8%) and > 30 days in four (5.9%): only one man 
presented within one day; HSV-2 antibodies were not detected in 11 of the 68 men, six of 
whom presented between 1-3 days and five between 4-7 days after onset of symptoms. 
The delay before attending in the 39 subjects (overall = 54, data for 39) with GUD and no 
pathogens identified was: 1-3 days in four (10.3%), 4-7 days in 17 (43.6%), 8-14 days in 
eight (20.5%), 15-30 days in three (7.7%) and > 30 days in seven (17.9%). There was 
little difference in the delay before attending between those with either genital herpes or 
no pathogens identified. 
 
Genital ulcers, dysuria, urethral discharge 
 
Seventy nine of the 165 (47.8%) patients with confirmed ulcers on examination  
complained either initially or during the clinical examination and further questioning of 
either urethral discharge and/or dysuria or were found to have urethral discharge. In this 
group, the following STIs were identified- gonorrhoea and/or chlamydia in 19 and 
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trichomoniasis in 13 including three with both gonorrhoea and chlamydia, one each with 
gonorrhoea or chlamydia. Of the 87 genital herpes cases confirmed by PCR, 44 (50.6%) 
complained of either dysuria or urethral discharge although only 15 complained of 
urethral discharge, eight had gonorrhoea, an additional three had chlamydia and three had 
trichomoniasis (one with gonorrhoea and one with chlamydia).  All the patients with both 
ulcers confirmed on examination and urethral discharge/dysuria received treatment for 
chancroid, syphilis, gonorrhoea and chlamydia although only five additional co-
infections with syphilis, all with low RPR titres were identified. 
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DISCUSSION 
 
We found a notable inconsistency between patients’ symptoms and what was found on 
clinical examination.  The addition of prompting to patients’ spontaneous complaints 
increased the sensitivity but decreased the specificity and PPV of history taking. Of note, 
we also found 45 patients who reported ulcers that did not have ulcers reinforcing the 
need both to spend time with patients to probe about other complaints and conduct a 
clinical genital examination to include retracting the foreskin in uncircumcised men.  
 
The high prevalence of HSV-2 identified from genital ulcers and associated dysuria 
cautions against providing empiric treatment for gonorrhea and chlamydia in ulcer 
patients with dysuria but without urethral discharge.  Our study found that about half of 
the 165 subjects with a genital ulcer confirmed on examination were also treated for 
urethritis although only 19 (11.5%) had either gonorrhoea or chlamydia, 15 (78.9%) of 
whom complained of urethral discharge. A previous study in mineworkers from South 
Africa concluded that because of the significant prevalence of urethritis in patients with 
GUD, syndromic management based on the presence of ulcers alone was inappropriate 
[17]. We found much lower prevalences of concomitant infections with gonorrhoea and 
chlamydia which may reflect the fact that contact with sex workers with high prevalence 
rates of gonorrhoea and chlamydia was much higher in the mineworker group than in 
Durban [12]. We did find TV in the urethra of 13 ulcer cases that had tests for TV and 
there could be a case for giving metronidazole for urethritis symptoms as in Malawi [18].  
 
Although the emergence of herpes in Africa was identified some time ago, strategies to 
deal with this have been slow to emerge. This is partly due to the cost of anti-herpes 
medication and also the self-limiting nature of the condition. We found that about 6% of 
our patients with genital HSV-2 infection presented either within 1 day of symptoms or 
greater than 30 days, outside of which time treatment is usually not indicated other than 
in primary cases or HIV positive subjects. However, 77% of our subjects with HSV-2 
positive ulcers were also HIV positive. Amongst STI clinic attenders with GUD in 
Malawi, an unweighted algorithm with a HSV-2 prevalence of 35% and chancroid of 
30%, concluded that men aged > 25 years with ulcers, symptoms > one week, shallow or 
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deep ulcers with or without lymph nodes could be treated for herpes, chancroid and 
syphilis although herpes treatment was not given routinely [19]. Although suppressive 
therapy is more effective than patient-initiated episodic treatment, the latter is a much 
cheaper option than and could be tried in our population [20, 21]. However, this would 
require specific education about recurrent episodes of genital ulceration and would need 
the provision of adequate levels of motivated trained staff in STI clinics.  
 
Our study identified LGV as the cause of ulceration in 13.6% of cases. We also identified 
LGV in a few cases without ulcers but with inguinal lymphadenopathy and one case with 
balanitis. This raises the question about onward transmission from individuals without an 
obvious source of infective material The reasons for the significant LGV prevalence are 
unclear but improved diagnostics have undoubtedly been a factor. Eighty six per cent of 
our LGV cases were HIV positive, a similar level to those with either herpes or ulcers 
with no cause identified. The clinical diagnosis of LGV is difficult and local syndromic 
management may not be adequate in that treatment with erythromycin was given for five 
days whereas WHO advise two weeks or even longer for definitive treatment [10]. 
However, good responses to treatment have been reported previously in Durban after five 
days of erythromycin and we would recommend that patients are followed up after 7 days 
if they are not improving significantly [7]. 
 
Despite technological advances, a significant number of ulcers cases were seen in whom 
no definitive diagnosis could be made. We believe that a large proportion of these are due 
to genital herpes. Our study showed that the most frequent delay in those with HSV-2 
PCR positive ulcers was 4-7 days. Given this delay it may be that the PCR sensitivity 
would be below that expected both in this group and those with older HSV ulcers that 
were resolving spontaneously as reported elsewhere [22]. Also, we enrolled patients who 
had received antibiotics in the previous two weeks and some of these may have had 
ulcers due to chancroid, LGV or syphilis infections not identified by PCR. 
 
Chancroid, syphilis and donovanosis have diminished considerably in Durban over the 
last 15 years. The reasons for this are probably multifactorial. Firstly, it could reflect 
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expanded access and higher quality syndromic management than that prior to the 1990’s 
when tetracycline rather than erythromycin was prescribed widely to cover chancroid and 
benzathine penicillin administration for syphilis was patchy. The long delays in seeking 
health care seen previously with donovanosis appear to have been resolved by increased 
awareness of and willingness to treat at the primary care level. In addition condom use 
has increased although levels of use are still quite low [12].  
 
The management of possible cases of syphilis still presents problems. Syphilis has 
decreased significantly to less than 5% of ulcers but treatment is still recommended for 
syphilis in all cases of GUD. This means that those with genital herpes and recurrent 
herpes are treated for syphilis every time they attend with genital ulcers and this impacts 
considerably on staff costs and time. One way of resolving this issue might be to do an 
on-site RPR test in those with ulcer symptoms of more than 14 days duration when the 
RPR test has a high sensitivity for detecting early syphilis. The downside of this option 
would be that a very small number of syphilis ulcers might be missed. However, this 
would obviate the need for unnecessary benzathine penicillin injections in the vast 
majority and would free up time for the RPR test. Furthermore, those with positive RPR 
results could be treated with three injections of benzathine penicillin to cover latent 
syphilis rather than the one injection that they receive currently. 
 
Although algorithms for GUD are generally held in higher regard than those for other STI 
syndromes conditions [23], this situation has changed with the emergence of genital 
herpes and there must be real concerns about syndromic management of GUD and the 
mixed messages of giving treatment for syphilis and chancroid but not herpes in those 
with genital herpes particularly in patients with a high prevalence of HIV.  
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Table 1: Presentation and microbial aetiology of patients with genital ulcers amongst STI clinic attenders.  
 
 
    Aetiology of GUD (n=161)1 
Genital ulcer symptom Number 
of men 
 
N=650 
genital ulcers 
seen on 
examination 
N=165 
Number 
swabbed 
 
N=162 
HSV2 
n=87 
LGV3 
n=22 
TP4 
n=6 
HD5 
n=2 
No 
pathogens 
isolated 
n=54 
Duration of spontaneously 
reported genital ulceration: 
1-3 
4-7 
8-14 
15-30 
<30 
Missing 
 
 
 
 
 
 
 
 
 
 
 
 
16 
32 
8 
8 
4 
19 
 
 
1 
6 
3 
4 
2 
6 
 
 
- 
3 
0 
1 
- 
2 
 
 
- 
2 
0 
0 
- 
- 
 
 
4 
17 
8 
3 
7 
15  
Total reporting genital 
ulceration spontaneously 
161 
(24.8) 
128 (79.5) 128 65 20 5 1 47 
Additional reporting genital 
ulceration on direct 
questioning 
30 (4.6) 18 (60.0) 18 11 1 1 1 4 
Total genital 
ulceration(spontaneous and 
direct questioning 
191 
(29.4) 
146 (76.4) 145 76 21 6 2 51 
No genital ulcers reported 459 
(70.6) 
19 (4.1) 17 11 3 0 0 3 
1: 1 case of clinical donovanosis; 2: Herpes Simplex virus (HSV), includes 7 mixed infections with lymphogranuloma venereum (LGV);  3: LGV, includes 7 mixed infections with HSV, 1 with 
Treponema Pallidum (TP), 1 with Hemophilus ducreyi (HD);
 
4: TP, includes 1 mixed infection with LGV;
 
5: HD, includes 1 mixed infection with LGV 
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Table 2: Validity of self reported and prompted symptoms of genital ulcers in men with genital ulceration on clinical 
examination 
 
 
 
Genital ulceration 
symptoms 
Genital ulcers seen on clinical examination 
 Sensitivity (%) Specificity (%) Positive predictive value (%) Negative predictive value (%) 
Unprompted 128/165 (77.6) 452/485 (93.2) 128/161 (79.5) 452/489 (93.2) 
Prompted 146/165 (88.5) 440/485 (90.7) 146/191 (76.4) 440/459 (95.9) 
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